Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation

被引:72
|
作者
Clarkesmith, Danielle E. [1 ]
Pattison, Helen M. [2 ]
Khaing, Phyo H. [3 ]
Lane, Deirdre A. [1 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Sandwell & West Birmingham Hosp NHS Trust, Dudley Rd, Birmingham B18 7QH, W Midlands, England
[2] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England
[3] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England
关键词
International Normalized Ratio [standards; Patient Education as Topic; Administration; Oral; Anticoagulants [administration & dosage; adverse effects; Atrial Fibrillation [blood; complications; Chronic Disease; Decision Support Techniques; Drug Monitoring [methods; standards; Medication Adherence; Randomized Controlled Trials as Topic; Self Care [methods; Stroke [blood; etiology; prevention & control; Aged; Humans; Middle Aged; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; INTERNATIONAL NORMALIZED RATIO; COMPUTERIZED DECISION-SUPPORT; HEART RHYTHM ASSOCIATION; SELF-MANAGEMENT PROGRAM; VS. USUAL CARE; ORAL ANTICOAGULATION; WARFARIN THERAPY; ANTITHROMBOTIC THERAPY;
D O I
10.1002/14651858.CD008600.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current guidelines recommend oral anticoagulation therapy for patients with atrial fibrillation (AF) with one or more risk factors for stroke; however, anticoagulation control (time in therapeutic range (TTR)) with vitamin K antagonists (VKAs) is dependent on many factors. Educational and behavioural interventions may impact patients' ability to maintain their international normalised ratio (INR) control. This is an updated version of the original review first published in 2013. Objectives To evaluate the effects of educational and behavioural interventions for oral anticoagulation therapy (OAT) on TTR in patients with AF. Search methods We updated searches from the previous review by searching the Cochrane Central Register of Controlled Trials (CENTRAL) and the Database of Abstracts of Reviews of Effects (DARE) in The Cochrane Library (January 2016, Issue 1), MEDLINE Ovid (1949 to February week 1 2016), EMBASE Classic + EMBASE Ovid (1980 toWeek 7 2016), PsycINFO Ovid (1806 toWeek 1 February 2016) and CINAHL Plus with Full Text EBSCO (1937 to 16/02/2016). We applied no language restrictions. Selection criteria We included randomised controlled trials evaluating the effect of any educational and behavioural intervention compared with usual care, no intervention, or intervention in combination with other self-management techniques among adults with AF who were eligible for, or currently receiving, OAT. Data collection and analysis Two of the review authors independently selected studies and extracted data. Risk of bias was assessed using the Cochrane 'Risk of bias' tool. We included outcome data on TTR, decision conflict (patient's uncertainty in making health-related decisions), percentage of INRs in the therapeutic range, major bleeding, stroke and thromboembolic events, patient knowledge, patient satisfaction, quality of life (QoL), beliefs about medication, illness perceptions, and anxiety and depression. We pooled data for three outcomes - TTR,anxiety and depression, and decision conflict - and reported mean differences ( MD). Where insufficient data were present to conduct a meta-analysis, we reported effect sizes and confidence intervals (CI) from the included studies. We evaluated the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Main results Eleven trials with a total of 2246 AF patients (ranging from 14 to 712 by study) were included within the review. Studies included education, decision aids, and self-monitoring plus education interventions. The effect of self-monitoring plus education on TTR was uncertain compared with usual care (MD 6.31, 95% CI -5.63 to 18.25, I-2 = 0%, 2 trials, 69 participants, very low-quality evidence). We found small but positive effects of education on anxiety (MD -0.62, 95% CI -1.21 to -0.04, I-2 = 0%, 2 trials, 587 participants, low-quality evidence) and depression (MD -0.74, 95% CI -1.34 to -0.14, I-2 = 0%, 2 trials, 587 participants, low-quality evidence) compared with usual care. The effect of decision aids on decision conflict favoured usual care (MD -0.1, 95% CI -0.17 to -0.02, I-2 = 0%, 2 trials, 721 participants, low-quality evidence). Authors' conclusions This review demonstrates that there is insufficient evidence to draw definitive conclusions regarding the impact of educational or behavioural interventions on TTR in AF patients receiving OAT. Thus, more trials are needed to examine the impact of interventions on anticoagulation control in AF patients and the mechanisms by which they are successful. It is also important to explore the psychological implications for patients suffering from this long-term chronic condition.
引用
收藏
页数:82
相关论文
共 50 条
  • [41] Cognitive impairment in patients with atrial fibrillation: What is the importance of anticoagulant therapy?
    Capobianco, Giovanni
    MONALDI ARCHIVES FOR CHEST DISEASE, 2018, 88 (02) : 17 - 18
  • [42] Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation
    Lasica, Ratko
    Djukanovic, Lazar
    Popovic, Dejana
    Savic, Lidija
    Mrdovic, Igor
    Radovanovic, Nebojsa
    Radovanovic, Mina Radosavljevic
    Polovina, Marija
    Stojanovic, Radan
    Matic, Dragan
    Uscumlic, Ana
    Asanin, Milika
    MEDICINA-LITHUANIA, 2022, 58 (03):
  • [43] Pitfall in the anticoagulant therapy in patients with paroxysmal atrial fibrillation and heart failure
    Lin, Yenn-Jiang
    Lin, Chin-Yu
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10)
  • [45] Oral anticoagulant therapy in atrial fibrillation older patients with previous bleeding
    Bo, Mario
    Giannecchini, Francesco
    Papurello, Martina
    Brunetti, Enrico
    MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (01) : 126 - 129
  • [46] Left atrial appendage contraction and indication of anticoagulant therapy in patients with paroxysmal atrial fibrillation
    Dai, K.
    Yamaji, T. Y.
    Oono, M. O.
    Takeuchi, A. T.
    Hashimoto, H. H.
    Harima, A. H.
    Ooi, K. O.
    Nakama, Y. N.
    Nishioka, K. N.
    Sakai, K. S.
    Otsuka, M. O.
    Miura, F. M.
    Shimatani, Y. S.
    Masaoka, Y. M.
    Inoue, I. I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 304 - 304
  • [47] The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation
    Ezekowitz, MD
    Falk, RH
    MAYO CLINIC PROCEEDINGS, 2004, 79 (07) : 904 - 913
  • [48] PRACTICAL ASPECTS OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION
    Kobalava, Zh. D.
    Shavarov, A. A.
    KARDIOLOGIYA, 2018, 58 : 42 - 55
  • [49] Impact of anxiety disorders on adherence to anticoagulant therapy in patients with atrial fibrillation
    Fomicheva, Anastasia V.
    Troshina, Daria V.
    Simonov, Anatoly N.
    Kopylov, Philipp Iu.
    Andreev, Denis A.
    Volel, Beatrice A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (09) : 1085 - 1093
  • [50] Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
    Seiffge, David J.
    De Marchis, Gian Marco
    Koga, Masatoshi
    Paciaroni, Maurizio
    Wilson, Duncan
    Cappellari, Manuel
    Macha, Kosmas
    Tsivgoulis, Georgios
    Ambler, Gareth
    Arihiro, Shoji
    Bonati, Leo H.
    Bonetti, Bruno
    Kallmuenzer, Bernd
    Muir, Keith W.
    Bovi, Paolo
    Gensicke, Henrik
    Inoue, Manabu
    Schwab, Stefan
    Yaghi, Shadi
    Brown, Martin M.
    Lyrer, Philippe
    Takagi, Masahito
    Acciarrese, Monica
    Jager, Hans Rolf
    Polymeris, Alexandros A.
    Toyoda, Kazunori
    Venti, Michele
    Traenka, Christopher
    Yamagami, Hiroshi
    Alberti, Andrea
    Yoshimura, Sohei
    Caso, Valeria
    Engelter, Stefan T.
    Werring, David J.
    ANNALS OF NEUROLOGY, 2020, : 677 - 687